Budget Amount *help |
¥3,900,000 (Direct Cost: ¥3,000,000、Indirect Cost: ¥900,000)
Fiscal Year 2011: ¥1,820,000 (Direct Cost: ¥1,400,000、Indirect Cost: ¥420,000)
Fiscal Year 2010: ¥2,080,000 (Direct Cost: ¥1,600,000、Indirect Cost: ¥480,000)
|
Research Abstract |
We have established ex vivo gene transfer system using genetically-modified blood outgrowth endothelial progenitor cells(BOECs) which are capable of synthesizing therapeutic levels of plasma FVIII over a prolonged time periods.^<20> Using this ex vivo gene transfer strategy, we can provide for the safe and efficacious delivery of FVIII following subcutaneous implantation of BOECs in hemophilia A mouse model. Now, we would like to try this strategy in hemophilia A dog model.
|